I summarize the key findings of a 6th-generation hs-cTnT assay, including its population-based reference percentiles and prognostic utility at ESC. With age and sex based hs-Tn and NT-proBNP cutoffs now in both HF guidelines and AMI definitions we can aim for more optimal diagnostic and prognostication, rather than a one size fits all.